Clinical Trials
6 trialsNCT07426757 2026-06-01
An Open-Label Study to Evaluate PF-07994525 in Participants With Advanced Cancers
Pfizer
Phase 1 Recruiting
NCT06038058 2025-12-30
A Study of BRY812 for Injection Alone in Subjects With Advanced Malignancies
BioRay Pharmaceutical Co., Ltd.
Phase 1 Recruiting
NCT06937957 2025-11-21
A Study of BR111 in Patients With Advanced Malignancies
BioRay Pharmaceutical Co., Ltd.
Phase 1 Recruiting
NCT06717880 2025-02-12
A Study of IBI363 in Combination With Bevacizumab or Furuitinib in Subjects With Advanced Colorectal Cancer
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Phase 1 Recruiting
NCT04651348 2024-11-20
A Clinical Study of MIL95 in Advanced Malignancies.
Beijing Mabworks Biotech Co., Ltd.
Phase 1 Recruiting
NCT06468098 2024-07-18
A Study of IBI363 in Subjects With Advanced Malignancies
Innovent Biologics (Suzhou) Co. Ltd.
Phase 1 Recruiting